TH E
JO U R N A L o f th e
A M E R IC A N
D E N T A L
A S S O C IA T IO N
M id-Monthly Issue V ol. 32
S E P T E M B E R 15, 1945
N o. 18
T H E C O U N C IL O N D E N T A L T H E R A P E U T IC S O F T H E A M E R IC A N D E N T A L A S S O C IA T IO N T h e C ouncil on Dental Therapeutics, which is a standing comm ittee o f the Am erican D ental Association, was estab lished in 1930 primarily for the purpose o f gathering and disseminating inform a tion to protect the dental profession in the prescribing and use o f proprietary medicinal and dental products. In this work, the C ouncil is aided by the Bureau o f Chemistry, which was established in 1927. In 1943, the scope o f the Council was enlarged to include devices and physical therapy apparatus w hich have dental application. Members o f C ouncil.— T he Council, whose members are elected by the House o f Delegates for terms o f six years, must have at least six dental members. T he balance may be selected from scientists in other groups. T h e present members o f the C ouncil are: J. H ow ard Brown, Ph.D., Sc.D ., Associate Professor o f Bacteriology, Johns Hopkins University; Edward C. Dobbs, D .D .S ., Associate Professor of Pharma cology and Therapeutics, University o f
M aryland, School o f Dentistry; Paul J. Hanzlik, M .D ., vice-chairm an o f the Council, Professor o f Pharmacology, Stanford University School o f M ed icin e ; T hom as J . Hill, D .D .S ., Professor o f Clinical Oral Pathology and Therapeu tics, Western Reserve University School o f Dentistry; H arold Hillenbrand (ex officio ), Editor, J o u r n a l o f t h e A m e r i can D e n t a l A s s o c ia t io n ; M ilan A . Logan, Ph.D., Professor o f Biochemistry, University o f Cincinnati School of M e d i cin e; A rno B. Luckhardt, M .D ., Ph.D., L L .D ., Sc.D., Professor o f Physiology, University o f C hicago; Harry Lyons, D .D .S., Professor o f O ral Pathology and Therapeutics and Periodontia, M edical College o f Virginia, School o f Dentistry; H . Berton M cC auley, D .D .S ., Assistant Professor o f Dentistry, University o f Rochester School of M edicine and D en tistry, o n leave with U . S. Public Health Service; V ictor C. M yers, Ph.D., Sc.D., D irector o f Clinical Biochemistry, W est ern Reserve University, Schools of M e d i cine and Dentistry; Floyd D . Ostrander,
C o n te n ts > C o u n c il o n D e n ta l T h e ra p e u t ic s ....................1197
N e w Y o r k R eso lu tio n .
1 224
P ro d u c ts " N o t A c c e p t a b le fo r A . D . R . " ......... 1 199
N e w D e a n s A p p o in t e d
1225
D e n ta l C o r p s R e g u la t io n s .............................1222
P re s id e n t's M e s s a g e
1226
.
T h e J o u r n a l o f t h e A m e r ic a n D e n t a l A s s o c ia t io n
danger and the abuses which arise from advertising directly or indirectly to the laity, and to advise the profession regard ing the use of drugs, chemicals, cosmetics, devices and physical therapy apparatus. O n the other hand, the Council encour ages and promotes those enterprises which are designed to increase knowl edge of dental materia medica and ther apeutics. Products which appear to con form to these rules are accepted and their essential features are described in the book “ Accepted Dental Remedies.” Unless otherwise determined at the time of acceptance, products admitted to “ A c cepted Dental Remedies” are retained for a period of three years, provided that, during that period, they comply with the rules and regulations which were in force at the time of their accept ance. A t the end of this period, all prod ucts are carefully reexamined for com pliance with existing rules. Accepted dentifrices are examined annually. Harold S. Smith, Chairman, Council on Dental Therapeutics.
D.D.S., M .S., Assistant Professor of D en tistry (in charge of materia medica and therapeutics), School of Dentistry, U ni versity of M ichigan; Harry B. Pinney, D.D.S. (ex officio), Secretary, American Dental Association ; Charles Sheard, Ph.D., Sc.D., Professor of Biophysics, M ayo Foundation, University of M inne sota and Director of the Division of Biophysical Research, M ayo Clinic, and Harold S. Smith, D.D .S., chairman of the Council. Donald A. W allace, Ph.D., is Secretary of the Council and Director of the Bureau of Chemistry. J. Roy Doty, Ph.D., is Associate Chemist of the Bu reau of Chemistry. Procedure.— Since its establishment, the Council on Dental Therapeutics has given consideration to thousands of den tal products, 600 of which are currently accepted. T h e Council examines these products for compliance with definite rules designed to prevent fraud or impo sition, undesirable secrecy, unnecessary
Donald A. Wallace, Secretary, Council on Dental Therapeutics.